Agencies grant 1-year extension of telemedicine prescribing flexibilities

The Drug Enforcement Administration and Department of Health and Human Services Nov. 15 issued a final rule extending certain telemedicine prescribing flexibilities for an additional year. As urged by the AHA, the agencies will waive the in-person visit requirement prior to the prescribing of controlled substances virtually until Dec. 31, 2025. The flexibilities were granted during the COVID-19 public health emergency and were set to expire at the end of this year.